Lantheus Holdings (LNTH) Other Accumulated Expenses (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Other Accumulated Expenses came in at $23.4 million in Q1 2026, up 79.11% year-on-year from $13.0 million in Q1 2025, and up 59.11% on a QoQ basis from $14.7 million in Q4 2025.

Lantheus Holdings (LNTH) Other Accumulated Expenses (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Other Accumulated Expenses data on file, last reported at $23.4 million in Q1 2026.

  • On a quarterly basis, Other Accumulated Expenses rose 79.11% year-over-year to $23.4 million in Q1 2026; TTM through Mar 2026 was $23.4 million, a 79.11% increase from a year earlier, with the FY2025 full-year figure at $14.7 million, up 41.28% from the prior year.
  • Other Accumulated Expenses for Q1 2026 stood at $23.4 million, up from $14.7 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for LNTH reached as high as $54.7 million in Q1 2024 and fell as low as $7.5 million in Q1 2022.
  • Historically, Other Accumulated Expenses has averaged $19.4 million across 5 years, with a median of $14.7 million in 2025.
  • Across the five-year window, Other Accumulated Expenses soared 572.0% in 2023 and tumbled 76.14% in 2025, its largest moves.
  • Year by year, Other Accumulated Expenses stood at $25.5 million in 2022, then slumped by 53.36% to $11.9 million in 2023, then decreased by 12.67% to $10.4 million in 2024, then soared by 41.28% to $14.7 million in 2025, then soared by 59.11% to $23.4 million in 2026.
  • Per Business Quant data, the three most recent Other Accumulated Expenses figures were $23.4 million in Q1 2026, $14.7 million in Q4 2025, and $20.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 23.37 Mn
Dec 31, 2025 14.69 Mn
Sep 30, 2025 20.93 Mn
Jun 30, 2025 9.80 Mn
Mar 31, 2025 13.05 Mn
Dec 31, 2024 10.40 Mn
Sep 30, 2024 14.83 Mn
Jun 30, 2024 16.80 Mn
Mar 31, 2024 54.69 Mn
Dec 31, 2023 11.91 Mn
Sep 30, 2023 22.56 Mn
Jun 30, 2023 11.16 Mn
Mar 31, 2023 50.38 Mn
Dec 31, 2022 25.53 Mn
Sep 30, 2022 11.14 Mn
Jun 30, 2022 11.01 Mn
Mar 31, 2022 7.50 Mn
Dec 31, 2021 5.35 Mn
Dec 31, 2020 6.13 Mn
Dec 31, 2019 2.10 Mn